Live Breaking News & Updates on Optera Therapeutics Corp
Stay updated with breaking news from Optera therapeutics corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Major players in the biosimilar lymphocyte modulator market are Pfizer, Biogen, Genentech, Novartis, and Celltrion. The global biosimilar lymphocyte. ....
Dublin, Nov. 08, 2022 (GLOBE NEWSWIRE) The "Biosimilar Lymphocyte Modulator Global Market Report 2022: By Drug, By Disease" report has been added to . ....
Share this article Share this article ResearchAndMarkets.com s offering. Biosimilar Lymphocyte Modulator Global Market Report 2020-30: COVID-19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global biosimilar lymphocyte modulator market. Major players in the biosimilar lymphocyte modulator market are Pfizer, Biogen, Genentech, Novartis and Celltrion. The global lymphocyte modulator market is expected to decline from $1.29 billion in 2019 to $1.21 billion in 2020 at a compound annual growth rate (CAGR) of -5.57%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach $1.6 ....